View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, David A. Wohl, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.
David A. Wohl, MD
Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Expert HIV faculty analyze new data from CROI 2022, from Clinical Care Options (CCO)
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Jasjit Gill, BSPharm, PharmD
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: May 10, 2022
Expired:
May 9, 2023
Expert selections of important HIV data from CROI 2022, including current and investigational strategies for prevention, ART, comorbidities, and cure
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Daniel R. Kuritzkes, MD
Released: May 2, 2022
Clinical Care Options (CCO) expert audio: Drs Cristina Mussini and William Short discuss key data and recommendations for the use of novel therapies for HIV treatment and prevention
Cristina Mussini, MD
William R. Short, MD, MPH, AAHIVS
Released: May 2, 2022
Slides from Dr Michelle Collins-Ogle and Clinical Care Options (CCO): There are key HIV management considerations for pediatric patients
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Released: April 29, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.